These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 25820137)

  • 1. Matrix metalloproteinase-2 negatively regulates cardiac secreted phospholipase A2 to modulate inflammation and fever.
    Berry E; Hernandez-Anzaldo S; Ghomashchi F; Lehner R; Murakami M; Gelb MH; Kassiri Z; Wang X; Fernandez-Patron C
    J Am Heart Assoc; 2015 Mar; 4(4):. PubMed ID: 25820137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a Novel Heart-Liver Axis: Matrix Metalloproteinase-2 Negatively Regulates Cardiac Secreted Phospholipase A2 to Modulate Lipid Metabolism and Inflammation in the Liver.
    Hernandez-Anzaldo S; Berry E; Brglez V; Leung D; Yun TJ; Lee JS; Filep JG; Kassiri Z; Cheong C; Lambeau G; Lehner R; Fernandez-Patron C
    J Am Heart Assoc; 2015 Nov; 4(11):. PubMed ID: 26567374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emergence of a metalloproteinase / phospholipase A2 axis of systemic inflammation.
    Fernandez-Patron C; Leung D
    Metalloproteinases Med; 2015 Aug; 2():29-38. PubMed ID: 26491703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Role for Matrix Metalloproteinase 9 in Modulation of Cholesterol Metabolism.
    Hernandez-Anzaldo S; Brglez V; Hemmeryckx B; Leung D; Filep JG; Vance JE; Vance DE; Kassiri Z; Lijnen RH; Lambeau G; Fernandez-Patron C
    J Am Heart Assoc; 2016 Sep; 5(10):. PubMed ID: 27694328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix metalloproteinase-2 mediates a mechanism of metabolic cardioprotection consisting of negative regulation of the sterol regulatory element-binding protein-2/3-hydroxy-3-methylglutaryl-CoA reductase pathway in the heart.
    Wang X; Berry E; Hernandez-Anzaldo S; Takawale A; Kassiri Z; Fernandez-Patron C
    Hypertension; 2015 Apr; 65(4):882-8. PubMed ID: 25646300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of Systemic Metabolism by MMP-2: From MMP-2 Deficiency in Mice to MMP-2 Deficiency in Patients.
    Fernandez-Patron C; Kassiri Z; Leung D
    Compr Physiol; 2016 Sep; 6(4):1935-1949. PubMed ID: 27783864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical role of phospholipase A2 isoforms in advanced-stage ovarian carcinoma.
    Gorovetz M; Baekelandt M; Berner A; Trope' CG; Davidson B; Reich R
    Gynecol Oncol; 2006 Dec; 103(3):831-40. PubMed ID: 16919315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secretory phospholipase A2 promotes MMP-9-mediated cell death by degrading type I collagen via the ERK pathway at an early stage of chondrogenesis.
    Choi YA; Kim DK; Bang OS; Kang SS; Jin EJ
    Biol Cell; 2009 Nov; 102(2):107-19. PubMed ID: 19764901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deficiency of phospholipase A2 receptor exacerbates ovalbumin-induced lung inflammation.
    Tamaru S; Mishina H; Watanabe Y; Watanabe K; Fujioka D; Takahashi S; Suzuki K; Nakamura T; Obata JE; Kawabata K; Yokota Y; Murakami M; Hanasaki K; Kugiyama K
    J Immunol; 2013 Aug; 191(3):1021-8. PubMed ID: 23817419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of type IIA secretory phospholipase A2 inhibits cholesteryl ester transfer protein activity in transgenic mice.
    Hurt-Camejo E; Gautier T; Rosengren B; Dikkers A; Behrendt M; Grass DS; Rader DJ; Tietge UJ
    Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2707-14. PubMed ID: 24115030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemically modified non-antimicrobial tetracyclines inhibit activity of phospholipases A2.
    Pruzanski W; Stefanski E; Vadas P; McNamara TF; Ramamurthy N; Golub LM
    J Rheumatol; 1998 Sep; 25(9):1807-12. PubMed ID: 9733464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MMP production in human fibrosarcoma cells and their invasiveness are regulated by group IB secretory phospholipase A2 receptor-mediated activation of cytosolic phospholipase A2.
    Gorovetz M; Schwob O; Krimsky M; Yedgar S; Reich R
    Front Biosci; 2008 Jan; 13():1917-25. PubMed ID: 17981679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of sPLA2 and endothelial function: a substudy of the SPIDER-PCI trial.
    Lavi S; Thorpe K; Luca MC; Liuni A; Floras J; Horlick EM; Ing D; Osten MD; Overgaard CB; Lan J; Parker JD; Cantor WJ; Džavík V
    Can J Cardiol; 2012; 28(2):215-21. PubMed ID: 22281412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secreted Phospholipase A
    Martin R; Gutierrez B; Cordova C; Roman AS; Alvarez Y; Hernandez M; Cachofeiro V; Nieto ML
    Cells; 2020 Feb; 9(2):. PubMed ID: 32046347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isoforms of secretory group two phospholipase A (sPLA2) in mouse ocular surface epithelia and lacrimal glands.
    Wei Y; Pinhas A; Liu Y; Epstein S; Wang J; Asbell P
    Invest Ophthalmol Vis Sci; 2012 May; 53(6):2845-55. PubMed ID: 22467583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo migration of transplanted myoblasts requires matrix metalloproteinase activity.
    El Fahime E; Torrente Y; Caron NJ; Bresolin MD; Tremblay JP
    Exp Cell Res; 2000 Aug; 258(2):279-87. PubMed ID: 10896779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sphingomyelin Regulates the Activity of Secretory Phospholipase A2 in the Plasma Membrane.
    Nakamura H; Wakita S; Yasufuku K; Makiyama T; Waraya M; Hashimoto N; Murayama T
    J Cell Biochem; 2015 Sep; 116(9):1898-907. PubMed ID: 25716287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of phospholipase A2 receptor increases susceptibility to cardiac rupture after myocardial infarction.
    Mishina H; Watanabe K; Tamaru S; Watanabe Y; Fujioka D; Takahashi S; Suzuki K; Nakamura T; Obata JE; Kawabata K; Yokota Y; Inoue O; Murakami M; Hanasaki K; Kugiyama K
    Circ Res; 2014 Jan; 114(3):493-504. PubMed ID: 24305469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Varespladib (A-002), a secretory phospholipase A2 inhibitor, reduces atherosclerosis and aneurysm formation in ApoE-/- mice.
    Fraser H; Hislop C; Christie RM; Rick HL; Reidy CA; Chouinard ML; Eacho PI; Gould KE; Trias J
    J Cardiovasc Pharmacol; 2009 Jan; 53(1):60-5. PubMed ID: 19129734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MMP-2: is too low as bad as too high in the cardiovascular system?
    Hardy E; Hardy-Sosa A; Fernandez-Patron C
    Am J Physiol Heart Circ Physiol; 2018 Nov; 315(5):H1332-H1340. PubMed ID: 30118342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.